100 related articles for article (PubMed ID: 24678912)
1. Cardiorenal protection in experimental hypertension with renal failure: comparison between vasopeptidase inhibition and angiotensin receptor blockade.
Halleck F; Schröder K; Holleck-Weithmann S; Kossmehl P; Kreutz R; Rothermund L
Clin Exp Hypertens; 2015; 37(1):26-32. PubMed ID: 24678912
[TBL] [Abstract][Full Text] [Related]
2. Impact of nephron number dosing on cardiorenal damage and effects of ACE inhibition.
Rothermund L; Lorenz M; Schnieber A; Eberson J; Bauhaus I; Bernhard Haug M; Schulz A; Keller F; Vetter R; Kreutz R
Am J Hypertens; 2011 Apr; 24(4):474-81. PubMed ID: 20864942
[TBL] [Abstract][Full Text] [Related]
3. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
4. Olmesartan combined with renal denervation reduces blood pressure in association with sympatho-inhibitory and aldosterone-reducing effects in hypertensive mice with chronic kidney disease.
Nishihara M; Takesue K; Hirooka Y
Clin Exp Hypertens; 2019; 41(3):211-219. PubMed ID: 29694249
[TBL] [Abstract][Full Text] [Related]
5. Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy.
Jovanovic D; Jovovic D; Mihailovic-Stanojevic N; Miloradovic Z; Naumovic R; Dimitrijevic J; Maksic N; Djukanovic L
Biomed Pharmacother; 2009 Sep; 63(8):571-6. PubMed ID: 19013753
[TBL] [Abstract][Full Text] [Related]
6. Diastolic properties in canine hypertensive left ventricular hypertrophy: effects of angiotensin converting enzyme inhibition and angiotensin II type-1 receptor blockade.
Hayashida W; Donckier J; Van Mechelen H; Charlier AA; Pouleur H
Cardiovasc Res; 1997 Jan; 33(1):54-62. PubMed ID: 9059528
[TBL] [Abstract][Full Text] [Related]
7. Vasopeptidase inhibition prevents target organ damage and improves survival in spontaneously hypertensive rats.
Linz W; Schäfer S; Afkham F; Gerl M; Schmidts HL; Rütten H
J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):155-61. PubMed ID: 17094052
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis.
Weinberg EO; Schoen FJ; George D; Kagaya Y; Douglas PS; Litwin SE; Schunkert H; Benedict CR; Lorell BH
Circulation; 1994 Sep; 90(3):1410-22. PubMed ID: 8087951
[TBL] [Abstract][Full Text] [Related]
9. An extremely high dose of losartan affords superior renoprotection in the remnant model.
Fujihara CK; Velho M; Malheiros DM; Zatz R
Kidney Int; 2005 May; 67(5):1913-24. PubMed ID: 15840039
[TBL] [Abstract][Full Text] [Related]
10. Vasopeptidase Inhibition Corrects the Structure and Function of the Small Arteries in Experimental Renal Insufficiency.
Haltia O; Törmänen S; Eräranta A; Jokihaara J; Nordhausen K; Rysä J; Ruskoaho H; Tikkanen I; Mustonen J; Pörsti I
J Vasc Res; 2015; 52(2):94-102. PubMed ID: 26184548
[TBL] [Abstract][Full Text] [Related]
11. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
Kujal P; Chábová VČ; Vernerová Z; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Vaňourková Z; Husková Z; Opočenský M; Skaroupková P; Schejbalová S; Kramer HJ; Rakušan D; Malý J; Netuka I; Vaněčková I; Kopkan L; Cervenka L
Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1159-69. PubMed ID: 20880190
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
Ikeda Y; Nakamura T; Takano H; Kimura H; Obata JE; Takeda S; Hata A; Shido K; Mochizuki S; Yoshida Y
J Lab Clin Med; 2000 Apr; 135(4):353-9. PubMed ID: 10779052
[TBL] [Abstract][Full Text] [Related]
13. Combination Treatment With Antihypertensive Agents Enhances the Effect of Qiliqiangxin on Chronic Pressure Overload-induced Cardiac Hypertrophy and Remodeling in Male Mice.
Ye Y; Gong H; Wang X; Wu J; Wang S; Yuan J; Yin P; Jiang G; Li Y; Ding Z; Zhang W; Zhou J; Ge J; Zou Y
J Cardiovasc Pharmacol; 2015 Jun; 65(6):628-39. PubMed ID: 25806688
[TBL] [Abstract][Full Text] [Related]
14. Effects of dual blockade of Renin-Angiotensin system on concentric left ventricular hypertrophy in essential hypertension: a randomized, controlled pilot study.
Grandi AM; Solbiati F; Laurita E; Maresca AM; Nicolini E; Marchesi C; Gianni M; Guasti L; Venco A
Am J Hypertens; 2008 Feb; 21(2):231-7. PubMed ID: 18174880
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Lebel M; Rodrigue ME; Agharazii M; Larivière R
Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
[TBL] [Abstract][Full Text] [Related]
16. AT-1 receptor blockade prevents proteinuria, renal failure, hyperlipidemia, and glomerulosclerosis in the Imai rat.
Rodríguez-Iturbe B; Sato T; Quiroz Y; Vaziri ND
Kidney Int; 2004 Aug; 66(2):668-75. PubMed ID: 15253721
[TBL] [Abstract][Full Text] [Related]
17. Vasopeptidase inhibition normalizes blood pressure and restores endothelial function in renovascular hypertension.
Quaschning T; Hocher B; Ruhl S; Kraemer-Guth A; Tilgner J; Wanner C; Galle J
Kidney Blood Press Res; 2006; 29(6):351-9. PubMed ID: 17139187
[TBL] [Abstract][Full Text] [Related]
18. Enalapril in subantihypertensive dosage attenuates kidney proliferation and functional recovery in normotensive ablation nephropathy of the rat.
Krivosíková Z; Sebeková K; Spustová V; Lajdová I; Dzúrik R
Physiol Res; 1999; 48(6):429-35. PubMed ID: 10783907
[TBL] [Abstract][Full Text] [Related]
19. Effect of chronic tetrahydrobiopterin supplementation on blood pressure and proteinuria in 5/6 nephrectomized rats.
Podjarny E; Hasdan G; Bernheim J; Rashid G; Green J; Korzets Z; Bernheim J
Nephrol Dial Transplant; 2004 Sep; 19(9):2223-7. PubMed ID: 15252157
[TBL] [Abstract][Full Text] [Related]
20. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]